Source: Inflammation. Unidades: FMRP, FCFRP
Subjects: PÂNCREAS, DIABETES MELLITUS, CÉLULAS
ABNT
DAVANSO, Mariana Rodrigues et al. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, v. 42, n. 2, p. 449-462, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10753-018-00954-3. Acesso em: 23 ago. 2024.APA
Davanso, M. R., Caliári Oliveira, C., Couri, C. E. B., Covas, D. T., Leal, Â. M. de O., Voltarelli, J. C., et al. (2019). DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, 42( 2), 449-462. doi:10.1007/s10753-018-00954-3NLM
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1007/s10753-018-00954-3Vancouver
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1007/s10753-018-00954-3